Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

Abstract Background Fluticasone furoate/Vilanterol trifenatate (FF/VI) is an inhaled corticosteroid/long-acting beta-agonist combination with a prolonged bronchodilator duration of action. We characterised the time-course of onset and offset of airway anti-inflammatory action of FF/VI, as assessed b...

Full description

Bibliographic Details
Main Authors: George Bardsley, Peter Daley-Yates, Amanda Baines, Rodger Kempsford, Mathew Williams, Tony Mallon, Irene Braithwaite, Kylie Riddell, Shashidhar Joshi, Philippe Bareille, Richard Beasley, James Fingleton, on behalf of the study team
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Respiratory Research
Subjects:
Asthma
Nitric oxide
Clinical trial
Online Access:http://link.springer.com/article/10.1186/s12931-018-0836-6

Internet

http://link.springer.com/article/10.1186/s12931-018-0836-6

Similar Items